Eversana Reveals new Market Access Portfolio
Eversana, an independent provider of global services to the life sciences industry, annouced Health Strategies Insights by Eversana, a market access research and insights portfolio to help life sciences innovators make more informed decisions throughout the product lifecycle.
“The evolution of our market intelligence capabilities strengthens Eversana's growing life science platform,” said Rod Cavin, General Manager for Health Strategies Insights by Eversana. “The product portfolio provides valuable market access insights to leading global biopharmaceutical companies in various phases of product development across a number of therapeutic areas-helping our clients achieve commercial success.”
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic Roadmap
March 17th 2025The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.
